Your browser doesn't support javascript.
loading
Cancer Core Europe: Leveraging Institutional Synergies to Advance Oncology Research and Care Globally.
Carmona, Javier; Chavarria, Elena; Donoghue, Kate; von Gertten, Christina; Oberrauch, Petra; Pailler, Emma; Scoazec, Giovanni; Weijer, Ruud; Balmaña, Judith; Brana, Irene; Brunelli, Cinzia; Delaloge, Suzette; Deloger, Marc; Delpy, Pierre; Ernberg, Ingemar; Fitzgerald, Rebecca C; Garralda, Elena; Lablans, Martin; Lëhtio, Janne; Lopez, Carlos; Fernández, Maialen; Miceli, Rosalba; Nuciforo, Paolo; Perez-Lopez, Raquel; Provenzano, Elena; Schmidt, Marjanka K; Serrano, Cesar; Steeghs, Neeltje; Tamborero, David; Wirta, Valtteri; Baird, Richard D; Barker, Karen; Barlesi, Fabrice; Baumann, Michael; Bergh, Jonas; de Braud, Filippo; Fizazi, Karim; Fröhling, Stefan; Piris-Giménez, Alejandro; Seamon, Kenneth; Van der Heijden, Michiel S; Zwart, Wilbert; Tabernero, Josep.
Afiliação
  • Carmona J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Chavarria E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Donoghue K; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • von Gertten C; Karolinska Institutet, Stockholm, Sweden.
  • Oberrauch P; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Pailler E; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Scoazec G; Gustave Roussy, Villejuif, France.
  • Weijer R; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Balmaña J; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Brana I; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Brunelli C; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Delaloge S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Deloger M; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Delpy P; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Ernberg I; Interception Programme, Department of Cancer Medicine, Gustave Roussy, Villejuif, France.
  • Fitzgerald RC; Gustave Roussy, Villejuif, France.
  • Garralda E; Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lablans M; Complex Medical Informatics, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
  • Lëhtio J; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
  • Lopez C; Department of Microbiology, Tumor and Cell Biology (MTC), Cancer Center Karolinska (CCK) & Biomedicum. Karolinska Institutet, Stockholm, Sweden.
  • Fernández M; Department of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.
  • Miceli R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Nuciforo P; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Perez-Lopez R; Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Provenzano E; Complex Medical Informatics, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
  • Schmidt MK; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
  • Serrano C; Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.
  • Steeghs N; Karolinska University Hospital, Stockholm, Sweden.
  • Tamborero D; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Wirta V; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Baird RD; Unit of Biostatistics for Clinical Research, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Barker K; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Barlesi F; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Baumann M; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Bergh J; Division of Molecular Pathology, NKI Center for Early Diagnostics, Lead Early Detection Research Theme, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • de Braud F; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Fizazi K; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Fröhling S; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Piris-Giménez A; Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.
  • Seamon K; Karolinska University Hospital, Stockholm, Sweden.
  • Van der Heijden MS; Department of Microbiology, Tumor and Cell Biology, Karolinska Instiutet, Stockholm, Sweden.
  • Zwart W; Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
  • Tabernero J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Cancer Discov ; 14(7): 1147-1153, 2024 Jul 01.
Article em En | MEDLINE | ID: mdl-38870393
ABSTRACT
Cancer Core Europe brings together the expertise, resources, and interests of seven leading cancer institutes committed to leveraging collective innovation and collaboration in precision oncology. Through targeted efforts addressing key medical challenges in cancer and partnerships with multiple stakeholders, the consortium seeks to advance cancer research and enhance equitable patient care.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncologia / Neoplasias Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncologia / Neoplasias Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article